SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: July 10, 2007
(Date of earliest event reported)
VASOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-18105 11-2871434
-------- ------- ------------
(State or other (Commission File (IRS Employer
jurisdiction of incorporation) Number) Identification No.)
180 Linden Avenue, Westbury, New York 11590
-------------------------------------------------------------------------
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code (516) 997-4600
-------------
-------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
[ ] Pre-commencement communications pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)
Item 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS; COMPENSATORY ARRANGEMENTS OF
CERTAIN OFFICERS
(b) On July 10, 2007, Thomas Glover resigned as a director of the Company.
Mr. Glover will continue to act as a consultant to the Company.
(d) On July 10, 2007, the Board of Directors appointed Dr. Derek Enlander
and Behnam Movaseghi as Directors. Dr. Enlander will also be serving
on the Compensation Committee.
Dr. Enlander, a Diplomate of the subdivision of Internal Medicine of
the American Board of Nuclear Medicine, has been, since 1983, in
private practice as well as an Attending Physician on the Faculty of
Medicine at Mount Sinai Medical Center in New York City. He is also a
Director of the New York CFIDS Center since 1983. He was an Assistant
Professor at Columbia University from 1976-1980. From 1980-1983, Dr.
Enlander was the Associate Director of the Division of Nuclear
Medicine at NYU. Dr. Enlander is the author of numerous books and
academic papers.
Mr. Behnam Movaseghi is a Certified Public Accountant and has been
Treasurer and Chief Financial Officer of Kerns Manufacturing
Corporation since 1990. For approximately ten years prior therto, Mr.
Movaseghi was a tax and financial consultant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VASOMEDICAL, INC.
Date: July 16, 2007
By: /s/ John C. K. Hui
-------------------------------------
John C. K. Hui
President and Chief Executive Officer